PolarityTE Inc. (PTE) |
|
1.69 -0.01 (-0.59%)
|
02-14 16:00 |
|
Open: |
1.7 |
Pre. Close: |
1.7 |
|
High:
|
1.71 |
Low:
|
1.67 |
|
Volume:
|
1,341,329 |
Market Cap:
|
45M |
|
|
|
|
PolarityTE, Inc., a biotechnology and regenerative biomaterials company, focuses on discovering, designing, and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine and Contract Services. It offers SkinTE, a tissue product for treatment of defects of the skin, as well as contract research services. The company also develops OsteoTE, an autologous homologous bone regeneration product; and CartTE, an autologous cartilage regeneration product. In addition, it develops AdipoTE to optimize the delivery of autologous fat; AngioTE for vascular regeneration; NeuralTE for peripheral nerve injuries of the extremities, as well as for patients with neuromas or chronic compression due to joint replacements, migraines, craniofacial injuries, carpal tunnel syndrome, and those who have undergone hernia or abdominal-based pr |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.713 - 1.721 |
1.721 - 1.728 |
|
Low:
|
1.65 - 1.659 |
1.659 - 1.667 |
|
Close:
|
1.677 - 1.691 |
1.691 - 1.703 |
|
Technical analysis |
as of: 2020-02-14 4:31:51 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 4.05 One year: 5.37 |
| Support: |
Support1: 1.64 Support2: 1.36 |
| Resistance: |
Resistance1: 3.47 Resistance2: 4.60 |
| Pivot: |
2.88  |
| Moving Average: |
MA(5): 2.27 MA(20): 3.10
MA(100): 2.99 MA(250): 5.69 |
| MACD: |
MACD(12,26): -0.28 Signal(9): -0.08 |
| Stochastic oscillator: |
%K(14,3): 2.26 %D(3): 8.53 |
| RSI: |
RSI(14): 28.79 |
| 52-week: |
High: 17.75 Low: 1.64 Change(%): -87.7 |
| Average Vol(K): |
3-Month: 43033 10-Days: 118257 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.PTE has closed above bottom band by 0.9%. Bollinger Bands are 114.8% wider than normal. The large width of the bands suggest high volatility as compared to PTE's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
2020-02-12
PolarityTE Announces Pricing of Public Offering of Common Stock and Warrants
SALT LAKE CITY--(BUSINESS WIRE)--PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced the pricing of an underwritten public offering of approximately 10,638,298 shares of its common stock and warrants to purchase up to 10,638,298 shares of its common stock. Each share of common stock is being sold together with a warrant to purchase one share of common stock for a combined purchase price of $2.35 pe
2020-02-11
PolarityTE Announces Public Offering of Common Stock and Warrants
SALT LAKE CITY--(BUSINESS WIRE)--PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that it has commenced an underwritten public offering of shares of its common stock and warrants to purchase shares of its common stock. Cantor Fitzgerald & Co. is acting as the sole book-running manager for the offering. Oppenheimer & Co. Inc. is acting as lead manager for the offering. PolarityTE intends
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NasdaqGS |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
27.24 |
| Shares Float (M) |
14.40 |
|
% Held by Insiders
|
50.21 |
|
% Held by Institutions
|
34.63 |
|
Shares Short (K)
|
4820 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-4.699 |
|
Book Value (p.s.)
|
2.100 |
|
PEG Ratio
|
-0.05 |
|
Profit Margin
|
|
|
Operating Margin
|
-1881.69 |
|
Return on Assets (ttm)
|
|
|
Return on Equity (ttm)
|
|
|
Qtrly Rev. Growth
|
92.4 |
|
Gross Profit (p.s.)
|
0.064 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-4.832 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-69.22 |
|
Levered Free Cash Flow (M)
|
|
Stock Valuations |
|
P/E
|
-0.36 |
|
P/E Growth Ratio
|
-0.01 |
|
P/BV
|
0.80 |
|
P/S
|
6.50 |
|
P/CF
|
-0.67 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
2016-01-14 |
|
Ex-Dividend Date
|
2016-01-11 |
|
Forward Dividend
|
|
|
Last Split Date
|
2016-07-31 |
|
Last Split Ratio
|
0.17 |
|
7 Binary Options
|
|
Your Ad Here
|
|
